Hospital Pharmacies Expected to Procure 46% Market Share for Rosai-Dorfman Disease (RDD) Therapeutics Market | FMI Study

During the forecast period 2023 to 2033, the Rosai-Dorfman Disease (RDD) Therapeutics market is expected to grow at a value of 6.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Rosai-Dorfman Disease (RDD) Therapeutics is expected to rise up to a market valuation of US$ 839.95 Million. The global RDD therapeutics market is expected to experience significant growth in the coming years, driven by advances in diagnostic technologies and the development of novel therapies.

RDD is typically diagnosed through a combination of clinical examination, imaging studies, and tissue biopsy. Once a diagnosis is confirmed, treatment options include watchful waiting, corticosteroid therapy, radiation therapy, and surgery. However, current treatments are often ineffective and can cause significant side effects, highlighting the need for more effective and targeted therapeutics.

Key companies are exploring the use of immune checkpoint inhibitors, such as PD-1 inhibitors, to treat RDD. These therapies work by blocking the immune checkpoints that cancer cells use to evade detection and destruction by the immune system. While still in early stages of development, these therapies hold great promise for the treatment of RDD.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16716

Key Takeaways from the Market Study

  • The Rosai-Dorfman Disease (RDD) Therapeutics market is expected to grow at a value of 6.9% CAGR in the forecast period 2023-2033
  • By distribution channel, hospital pharmacies are expected to possess 46% market share for Rosai-Dorfman Disease (RDD) Therapeutics market in 2023.
  • North America is expected to possess 40% market share for Rosai-Dorfman Disease (RDD) Therapeutics market in 2023.
  • Asia Pacific is expected to possess 35% market share for Rosai-Dorfman Disease (RDD) Therapeutics market in 2023.

“Development of targeted therapeutics and personalized medicine is expected to provide significant growth opportunities in the coming years.” states an FMI analyst

Competitive Landscape

Key players in the Rosai-Dorfman Disease (RDD) Therapeutics market are Teva Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Sun Pharmaceuticals Industries Ltd, Advanz Pharmaceticals, Novartis AG, Mylan N.V., Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd, Viatris Inc., Pfizer Inc.

  • Teva Pharmaceuticals Ltd, a key player in the Rosai-Dorfman Disease (RDD) Therapeutics market is focusing on investing in research and development to innovate medication for treating the ailment.
  • Zydus Pharmaceuticals, Inc, another key player in the Rosai-Dorfman Disease (RDD) Therapeutics market is focusing on integrating technology to understand the nature of the ailment and innovate medication for early-stage treatment.

Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16716

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Rosai-Dorfman Disease (RDD) Therapeutics market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of drug class (MEK-inhibitors, Immunosuppressants and modulators, Chemotherapy), Treatment (PET Scan, CT scan, MRI, Ultrasounds, Blood Tests) End User (Hospitals and Clinical Laboratories) Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA)

Key Segments Profiled in the Rosai-Dorfman Disease (RDD) Therapeutics Industry Survey

Drug Class:

  • MEK-inhibitors
    • Cobimetinib
    • Trametinib
    • Binimetinib
  • Immunosuppressants and modulators
    • Mercaptopurine
    • Azathioprine
    • Lenalidomide
    • Thalidomide
  • Chemotherapy
    • Cladribine
    • Cytarabine
    • Vinblastine
    • Hydroxyurea
    • Methotrexate

Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-16716

Treatment:

  • PET Scan
  • CT scan
  • MRI
  • Ultrasounds
  • Blood Tests

End User:

  • Hospitals
  • Clinical Laboratories

Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Global Progressive Multifocal Leukoencephalopathy Treatment Market to reach US$ 1.7 billion by 2033, growing at a 3% CAGR | FMI Report

The global progressive multifocal leukoencephalopathy treatment market is expected to garner a market value of US$ 1,320 million in 2023 and is expected to accumulate a market value of US$ 1,773.97 million by registering a CAGR of 3% in the forecast period 2023 to 2033. The market for progressive multifocal leukoencephalopathy treatment registered a CAGR of 2% in the historical period 2018 to 2022.

According to the latest studies, PML occurs in approximately one in 200,000 people. As per the same report, each year, it is estimated that 4,000 people develop PML in the United States and Europe combined. The increasing demand for these treatments is expected to lead to the development of new and innovative treatments, which will drive the growth of the market in the coming years.

North America is anticipated to acquire a market share of about 40% in the forecast period. This growth is attributed to the rising prevalence of the condition in the region. Furthermore, government initiatives and increase in the number of research partnerships are boosting the market growth across North America. Asia Pacific is a growing market due to a shift towards point-of-care healthcare. The increasing number of hospitals in India and China presents a promising market opportunity globally.

𝑮𝒆𝒕 𝑳𝒂𝒕𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16711

Key Takeaways from the Market Study

  • From 2018 to 2022, the Progressive Multifocal Leukoencephalopathy Treatment market grew at a CAGR of 2%.
  • The global Progressive Multifocal Leukoencephalopathy Treatment market is expected to grow with a 3% CAGR during 2023 to 2033.
  • As of 2033, the Progressive Multifocal Leukoencephalopathy Treatment Market is expected to reach US$ 1773.97 Million.
  • According to the FMI analysis, hospital pharmacies account for the largest market share.
  • North America is expected to possess 40% market share for the Progressive Multifocal Leukoencephalopathy Treatment market.
  • The South and East Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering progressive multifocal leukoencephalopathy treatment.” says an FMI analyst

𝑨𝒔𝒌 𝑨𝒏 𝑨𝒏𝒂𝒍𝒚𝒔𝒕@ https://www.futuremarketinsights.com/ask-question/rep-gb-16711

Market Competition

Key players in the market include pharmaceutical companies such as NeoImmuneTech, Neurimmune, GlaxoSmithKline Plc, Sanofi S.A., Gilead Sciences, Inc., Allergan Plc., Novartis AG, AbbVie Inc., and Bristol-Myers Squibb Company along with healthcare providers and technology companies among other global players.

  • In October 2022, Cellevolve Bio, Inc., a company focused on developing and commercializing cell therapies, announced that its Investigational New Drug (IND) application for CE-VST01-JC has been approved by the U.S. Food and Drug Administration (FDA). CE-VST01-JC is a JC Virus Specific T Cell Therapy that is being studied for the treatment of progressive multifocal leukoencephalopathy (PML) and has received orphan drug designation from the FDA.
  • The safety and effectiveness of CE-VST01-JC will be tested in a global, multi-center, randomized, double-blind, placebo-controlled Phase 2 study called ASCEND-JC. The study is expected to enroll up to 60 patients across the US, Canada, and EU, with the first patient enrollment anticipated in the first half of 2023.

More Insights Available

FMI, in its new offering, presents an unbiased analysis of the global progressive multifocal leukoencephalopathy treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of indication, treatment, distribution channel, end-users and region.

𝑩𝒖𝒚 𝑵𝒐𝒘/𝑷𝒖𝒓𝒄𝒉𝒂𝒔𝒆@ https://www.futuremarketinsights.com/checkout/16711

Key Segments Profiled in the Progressive Multifocal Leukoencephalopathy Treatment Industry Survey

Treatment:

  • Anti-retroviral Therapy
  • Antiviral/Anti JCV
  • Other Symptomatic

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Indication:

  • HIV/AIDS
  • Organ Transplantation
  • Multiple Sclerosis
  • Hematologic Malignancies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

3D Printed Medical Devices Market holds a share of US$ 799.8 million in 2023

During the anticipated period, the market for 3D printed medical devices is anticipated to grow at a strong CAGR of 16.3%. The market is expected to reach a value of US$ 3.6 billion by 2033, up from its current share of US$ 799.8 million in 2023.

[322 Pages Report] Currently heading towards a market value of over US$ 440 Mn, the global market for 3D printed medical devices is projected for stupendous growth at 16% CAGR during 2022- 2029. North America will remain the leading market for 3D printed medical device sales, whereas the market attractiveness of Asia Pacific has been rising notably.

The market growth is primarily assisted by advancements in 3D printing technology, surging government spending in healthcare sector, increasing usage of 3D printed medical devices for medical procedures, and relative simplification of the manufacturing process of 3D printed medical devices. Introduction of Computer-aided Design (CAD) for 3D printing can create trail ready devices, thereby reducing manufacturing time, time to market as well as operational cost.

Get Latest Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1501

Key Takeaways – 3D Printed Medical Devices Market Study

  • Although metals and alloys are most preferably used for 3D printed medical devices, biomaterial inks are expected to gain traction during the forecast period owing to their highly biocompatible and versatile physical properties.
  • PolyJet – InkJet 3D printing technology currently holds maximum share of 3D printed medical devices market. However, consistent development and adoption of innovative technologies may reduce the 3D printed medical devices market share of this technology during the forecast period.
  • Use of 3D printing technology in orthopedic implants is shaping the future of 3D printed medical devices market. It currently accounts for nearly half of the market value.
  • The consistently expanding patient pool and growing preference for personalized implants in joint replacement surgeries will remain key boosters to growth of 3D printed medical devices demand in orthopedics.

Asia Pacific has become the global hub of opportunities, and the leaders in 3D printed medical devices landscape have been eying the opportunity here – owing to the massive application scope, remarkably growing patient population, and relatively less manufacturing costs.

Who Is Winning?

Until late 2016, the key focus of most leading players in the 3d printed medical equipment market was geographic expansion through acquisition and merger. In May 2016, Johnson & Johnson announced collaboration with a subsidiary of HP Inc. for manufacturing personalized healthcare solutions at reduced costs through 3D printing techniques. J&J collaborated with Organovo to carry out feasibility study on bio printed human tissue for testing new medications to work with Carbon 3D, famous for ultra-fast Continuous Liquid Interface Production (CLIP) technology for production of custom surgical devices.

The focuse is now gradually shifting towards expansion through strategic partnerships to improve their distribution network. For instance, in 2017, Envision partnered with ScanSource, Inc. to deliver 3D printing solutions to resellers in the Americas. Similarly, in 2018, 3D Systems and Stryker announced distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for carniomaxillofacial specialty.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1501

Learn More About Report Inclusions

Future market insights offers a unique perspective and actionable insights on 3D printed medical devices market in its latest study, presenting historical demand assessment from 2014 – 2021 and projections from 2022 – 2029 based on application (orthopedic implants, dental implants, carnio-maxillofacial Implant), material type (metals and alloys, biomaterial inks and plastics) technology (stereolithography (SLA) – liquid-based 3D printing, selective layer sintering (SLS) – powder-based 3d printing, digital light processing(DLP), fused deposition modelling (FDM)-plastic filament extrusion-based, polyjet – inkjet 3D printing, electronic beam melting (EBM) ) end user (hospitals, ambulatory surgical centers, diagnostic centers) in seven key regions.

Key Market Segments Covered in 3D Printed Medical Devices Industry Research By Application : 

  • Orthopaedic Implants
  • Dental Implants
  • Cranio-maxillofacial Implants
  • Internal and External Prostheses

By Technology :

  • Stereolithography (SLA) – Liquid Based 3D Printing
  • Selective Layer Sintering (SLS) – Powder Based 3D Printing
  • Digital Light Processing(DLP)
  • Fused Deposition Modeling (FDM): Plastic Filament Extrusion Based
  • PolyJet / InkJet 3D Printing
  • Electronic Beam Melting (EBM)

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1501

By Distribution Channel :

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Material :

  • Plastics
    • Thermoplastics
    • Photopolymers
  • Biomaterial Inks
    • Polymers
    • Ceramics
    • Hydrogels
  • Metals and Alloys

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Gastro-retentive Drug Delivery Systems Market is expected to reach US$ 24.8 Billion by 2033

The Gastro-retentive Drug Delivery Systems Market revenues were estimated at US$ 13.3 Billion in 2022 and is anticipated to grow at a CAGR of 10.1% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 24.8 Billion.

Large drug firms’ investments to enhance gastro-retentive drug-delivery systems, along with the reduction in required doses due to enhanced bioavailability and an increase in the requirements for medications, have helped accelerate the market growth. The well-established efficacy of gastro-retentive drug delivery systems in treating a variety of stomach disorders such as peptic ulcer and gastric ulcer, as well as a growth in the incidence of H. Pylori infection, which can cause gastritis and gastric cancer, impart a significant impact on the market.

Get Latest Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16540

Gastro-retentive drug distribution technology has proven to be a useful way of regulating the administration of a wide range of medicinal substances while enhancing bioavailability. Advancements in controlled oral medication administration systems have been made in recent years because of technological advancements that overcome physical roadblocks such as unpredictable stomach emptying periods and short gastric residency times. By extending their dwell time in the upper GI tract, once-GRDDS can enhance oral bioavailability and therapeutic excellence.

Technological advancements for rate-controlled oral medication delivery systems are now overcoming physiological issues such as unexpected stomach emptying intervals and short gastric residency times. To address these issues, the gastro-retentive drug delivery system is designed for a longer stomach retention duration, which increases patient preference by extending the time available for medicine absorption.

North America is expected to account for significant revenue in the gastro-retentive drug delivery systems market, with a market projection of US$ 10 Billion. Regional expansion is expected to be facilitated by the introduction of improved gastro-retentive medication delivery technology and the implementation of novel treatment techniques in healthcare.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-16540

GRDDS are projected to be in high demand as the prevalence of gastrointestinal disorders grows in the United States and Canada, as they lengthen medication retention time in the stomach. Demand for these devices in the region is projected to be driven by the presence of a large patient pool. Rising research and development spending in emerging markets is expected to drive regional market expansion.

Competitive Analysis

Manufacturers will benefit from proprietary benefits such as industry research financing and product development agreements, which will help them contribute to the development of effective cancer diagnosis technologies. Obtaining patents and government clearances for new technology will also continue to be a key growth strategy. The key players in the market include Ranbaxy, F. Hoffmann La Roche, Pharmacia, GlaxoSmithKline, Lupin, Pfizer, Depomed, Galanix, Sun Pharma, and Alcon, Inc.

Few of the recent developments of key Gastro-retentive Drug Delivery Systems providers are as follows:

  • In 2020, Cadila Pharmaceuticals launched Esomeprazole tablets which will be used in treatment of hyperacidity and drug induced gastritis.
  • In 2020, Xiromed LLC launched 20mg Omperazole delayed release capsules. Omeprazole is cost effective generic product which can be used in treatment of gastroesophageal reflux disease and healing of erosive esophagitis.

Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-16540

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Gastro-retentive Drug Delivery Systems Market, presenting historical market data (2018-2022) and forecast statistics for the period of 2023-2033.

The study reveals essential insights by Type (High-Density System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, Floating Drug Delivery System, Others), by Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Market Segments Covered in Gastro-retentive Drug Delivery Systems  Industry Analysis

By Type:

  • High Density System
  • Expandable Drug Delivery System
  • Bioadhesive Drug Delivery System
  • Floating Drug Delivery System
  • Others

By Dosage Form:

  • Tablets
  • Liquid
  • Microspheres
  • Capsule
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Exosome Diagnostic and Therapeutics Market growing at a CAGR of 20.0% from (2022-2028)

The Exosomes Diagnostic and Therapeutic Market is expected to be worth USD 58.6 million in 2022 and USD 175.4 million by 2028, expanding at a CAGR of 20.0 percent during the forecast period (2022-2028).

Market Outlook:

Data Points Market Insights
Market Value 2021 US$ 46.7 Mn
Market Value 2028 US$ 175.4 Mn
CAGR 2022-2028 20.0%
Market Share of Top 5 Countries 75.3%

Future Market Insights in its recent research report titled “Exosome Diagnostic and Therapeutics Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” covers several factors that are influencing the robust growth of the global market. As per this research report, the global exosome diagnostic and therapeutic market is projected to expand at a high CAGR of 23.1% during the period of assessment.

Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6379

The exhaustive research publication includes key trends, opportunities, threats, growth drivers and challenges that impact the global exosome diagnostic and therapeutics market. Detailed pricing analysis of different exosome diagnostic and therapeutics across key regions is also discussed in the research study. The segmental analysis across North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Latin America, Japan and Middle East and Africa (MEA) is carried out which is used to track the future projections for a period of ten years, pertaining to value, of the global exosome diagnostic and therapeutics market.

Global Market for Exosome Diagnostic and Therapeutics: Underlying Forces Influencing Growth

The growth of global market for exosome diagnostics and therapeutics is influenced by several factors. Increasing need for screening and diagnosis of chronic diseases coupled with high therapeutic potential of exosomes are fuelling the adoption of exosome diagnostics and therapeutics. Moreover, introduction of explicit systems for analysis of proteins specific to exosomes, increasing research and development activities supported by favourable government policies across various regions and increasing popularity of exosome over CTC and ctDNA are expected to trigger the growth of the global market for exosome diagnostic and therapeutics market in the years to follow. On the contrary, lack of standardization and validation requirements for isolation of exosomes is expected to pose hindrances to the growth of the global market. Other factors negatively impacting the market’s growth include heavy investments in research and development and insufficient insurance coverage of costly cancer diagnostic tests.

Segmentation Highlights of the Global Exosome Diagnostic and Therapeutics Market

The global exosome diagnostic and therapeutics market is segmented on the basis of product type, application, end user and region.

In the region category, North America is estimated to be the largest with a high market lucrativeness. This region is expected to grow at a significant CAGR during the forecast period to touch a large market estimation by end of the assessment year, thus leading the global market. Moreover, Asia Pacific excluding Japan (APEJ) is the fastest growing region and is the second largest in terms of adoption and use of exosome diagnostics and therapeutics. APEJ is filled with high growth opportunities and is being targeted by several giants in this sector, such as Thermo Fisher Scientific.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-6379

By product type, reagents and kits are gaining high traction owing to increasing use in exosome diagnostics and therapeutics. The reagents and kits segment dominated the market in 2017 and is anticipated to continue with the trend in the coming years. This segment is also expected to expand at a high growth rate during the forecast period. The reagents and kits segment is expected to register a high CAGR of 28.2% throughout the period of forecast. The software segment is the second fastest growing segment spurring the growth of the global market.

In the application category, diagnostic segment is the largest as compared to therapeutics segment and is estimated to touch a value of over US$ 90 Mn by the end of the year of assessment, growing at a significant pace. Therapeutics segment is projected to expand at a CAGR of 29.0% throughout the period of assessment.

With respect to end user, the use of exosome diagnostic and therapeutics is largely observed in diagnostic centres. The diagnostic centres segment is expected to surpass other end user segments with a high market share and growth rate in the coming years.

Forecast Analysis of the Global Exosome Diagnostic and Therapeutics Market

According to the research report, the global market for exosome diagnostic and therapeutics is expected to grow at a high CAGR to reach an estimate of over US$ 150 Mn by the end of the year of assessment from a value of about US$ 19 Mn in 2017.

Competitive Landscape Shaping the Global Exosome Diagnostic and Therapeutics Market

Manufacturers of exosome diagnostic and therapeutics are focusing to raise capital required for launch of new products or research and development expenses through venture financing. Key companies such as

  • Thermo Fisher Scientific Inc.
  • NanoSomix Inc.
  • NX PHARMAGEN
  • Capricor Therapeutics Inc.
  • Exosome Diagnostics Inc.
  • Exiqon A/S (Aethlon Medical Inc.).
  • System Biosciences Inc.
  • Aegle Therapeutics AMS Biotechnology (Europe) Limited
  • Miltenyi Biotec.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6379

Market segmentation

By Product Type

    • Instrument
  • Software
  • Reagents and Kits

By Application

  • Diagnostics
  • Therapeutics

By End User

  • Hospitals
  • Cancer Institutes
  • Diagnostic Centres
  • Others

By Region

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Surface Plasmon Resonance Market rising from US$ 910.4 million in 2022 to US$ 1807.7 million in 2032

[Report of 342 Pages] Surface plasmon resonance market growth is anticipated, rising from US$ 910.4 million in 2022 to US$ 1807.7 million in 2032. The market is expected to grow at a CAGR of 7.1% over the course of the forecast period, according to FMI.

Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability of versatile products coupled with surface plasmon resonance to enhance the specificity of tests is an important factor that will bolster the demand for surface plasmon resonance. Imaging systems help in increasing throughput at a remarkable speed and with precise motion and consistency in report generation. Furthermore, the introduction of multifunctional products for improved outcomes is also expected to drive the growth of the surface plasmon resonance market over the forecast period.

The global surface plasmon resonance market is projected to reach a market value of US$ 770 Mn in 2019, increasing at a decent CAGR of 6% over the forecast period of 2019 – 2029.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-962

Key Takeaways of Surface Plasmon Resonance Market Study

  • The market share of imaging systems is evaluated to grow at a significant rate by the end of 2029, as these are the ideal solution for the analysis of label-free and multiplexed biomolecules.
  • Sales of surface plasmon resonance are envisaged to be higher in North America. Increasing adoption of imaging systems and biosensors in life science R&D is anticipated to boost the growth of the surface plasmon resonance market in the region.
  • Innovation while developing imaging software used in surface plasmon resonance for the analysis of kinetic parameters of biomolecular interactions is a key aspect for increasing the reproducibility of results. Companies are investing in R&D initiatives to introduce superior imaging devices with enhanced magnification, to observe the smallest deflection in the refractive index, thus aiding the growth of the surface plasmon resonance market.

“Increasing application of surface plasmon resonance in the field of drug discovery and medical imaging is contributing to the growth of the surface plasmon resonance market. Development of new technologies coupled with surface plasmon resonance, such as nanoparticle surface plasmon resonance and microfluidics, is playing an important role in the overall growth of the global surface plasmon resonance market.”

Adoption of Label-free Detection Technique for Analysis of Biomolecules

Detection of biological analytes through their physical properties is difficult. As a result, researchers rely on the addition of some sort of label to one or more of the analytes that need to be studied. Inclusion of this label for increasing specificity and accuracy has increased the cost of reagents and assays. To reduce assay cost and complexity while providing more qualitative information through labelled detection, adoption of the label-free detection technique such as surface plasmon resonance has increased, and is expected to fuel the growth of the global surface plasmon resonance market during the forecast period. The label-free detection technique simplifies the procedure by reducing the time and effort required for the development of the assay. Thus, increasing adoption of label-free detection techniques over labelled detection is expected to boost the growth of the global surface plasmon resonance market.

Want more insights?

The surface plasmon resonance market report, a new study by Future Market Insights, opines on the evolution of the global surface plasmon resonance market from 2014–2018, and presents demand projections for 2019–2029, on the basis of product type (imaging systems, sensor systems, and reagents), application (drug delivery, material science, and biosensors), and end user (academic and research institutes, food and beverage industry, biopharmaceutical companies, CROs, and others), across seven prominent regions.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-962

SURFACE PLASMON RESONANCE MARKET TAXONOMY

The global surface plasmon resonance market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

  • Imaging Systems
  • Sensor Systems
  • Reagents

Application

  • Drug Discovery
  • Material Science
  • Biosensors

End User

  • Academic & Research Institutes
  • Food & Beverage Industry
  • Biopharmaceutical Companies
  • CROs

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-962

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Revenue of PPG Biosensor-based Smart Watches to Swell at a CAGR of over 16% between 2023 and 2033, States Future Market Insights

Future Market Insights, a market research, and competitive intelligence provider, analyses that the demand for PPG Biosensors is anticipated to increase at a CAGR of 15.2% from 2023 to 2033, with an absolute dollar opportunity of US$ 1.5 Billion.

Factors like the growing number of CVD cases throughout the world, as well as people’s increased attention to fitness, are driving the worldwide market of PPG biosensors. During the projected period, technological advancements and the non-invasive nature of PPG biosensors are likely to fuel the market.

Get Latest Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16465

PPG biosensor technology is constantly evolving, resulting in the creation of several new devices that will improve the efficiency and accuracy of biosensors. Biosensors integrating artificial intelligence have been developed in recent years. For example, in 2019, researchers developed an AI classifier that can use a wearable wrist biosensor to diagnose a particular CVD called hypertrophic cardiomyopathy.

Because of the rising use of sophisticated technologies in healthcare, North America led the market for PPG biosensors in 2022. Nearly half of the population in the United States has a type of CVD that need continual monitoring. The FDA has authorized numerous PPGs in recent years, boosting the PPG biosensors market in the region.

Competitive Analysis

The leading PPG biosensors market companies are extensively spending on research and development to develop biosensor technologies for improved disease management and surveillance. Besides, the companies are also engaged in forming partnerships to expand their global footprint.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-16465

Some of the recent developments of key PPG biosensors providers are as follows:

  • In July 2022, Mitocon Biomed launched Oxysat, a pulse oximeter with an 18-month replacement warranty. The company owns the procurement, manufacturing, and distribution rights.
  • In April 2022, Amazfit Bip U Pro and BOAT Xplorer were released in India. PPG bio-tracking optical sensors in smartwatches continually measure heart rate.
  • In June 2020, Xiaomi Mi Band 5 was launched which had numerous new features, including a bigger OLED display, improved HR tracking, and magnetic charging. It had a PPG Biosensor installed in it which facilitated enhanced heart rate monitoring.

More Valuable Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the PPG Biosensors market, presenting historical market data (2018-2023) and forecast statistics for the period of 2023-2033.

The study reveals essential insights by Product Type (Pulse Oximeters, Smart Watches, Smart Wrist Bands and Other Product types), by Application (Heart Rate Monitoring, Blood-Oxygen Saturation, Blood Pressure and Other Applications), and across key regions (North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa).

Buy Now/Purchase@ https://www.futuremarketinsights.com/checkout/16465

Market Segments Covered in PPG biosensors Market Analysis

By Product Type:

  • Pulse Oximeters
  • Smart Watches
  • Smart Wrist Bands
  • Other Product types

By Application:

  • Heart Rate Monitoring
  • Blood-Oxygen Saturation
  • Blood Pressure
  • Other Applications

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Korea’s High Diabetic Population and Immigration of Individuals from Mongolia & China to Aid Tuberculous Meningitis Elimination Push

According to Future Market Insights, Korea is likely to emerge as a profitable market for tuberculous meningitis treatments between 2023 and 2033. The country is set to play a prominent role in shaping market expansion in the next ten years across Asia Pacific. An anticipated 6.5% CAGR is poised to drive acceleration of the Asia Pacific tuberculous meningitis market from 2023 to 2033.

In 2023, the global market for tuberculous meningitis treatments is expected to reach a value of US$150 billion. Between 2023 and 2033, a robust 7.2% CAGR is likely to propel the market to a US$ 300 billion valuation in 2033.

Get Latest Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16477

Population in Korea has a long history of tuberculosis. Following the end of the Korean War in 1953, around 6.5% of the population was diagnosed with active tuberculosis. To prevent the situation from going out of hand, the country’s government took a significant step in 1962, when it started the National Tuberculosis Program.

The program was effective in reducing the reported number of cases in the country. At present, Korea is also one of Asia Pacific’s most economically prosperous nations, and its economic status has allowed it to invest heavily in infrastructure to manage tuberculosis. However, tuberculosis still remains a cause for concern in the country.

Korea’s tuberculosis burden is a result of multiple factors. For starters, the country has a sizable elderly population. With aging, host immunity against the virus that causes tuberculosis wanes, and this is what makes the country’s elderly population prone to the disease.

Korea’s diabetic population is also on the rise. Growing prevalence of diabetes is indicative of weakened immune systems that are at risk of contracting tuberculosis. Rising immigrants from high-burden tuberculosis countries such as Mongolia, China, and Pakistan are also thought to have contributed to recurring tuberculosis outbreaks across Korea.

Public-private collaborations have been on the rise in Korea tuberculous meningitis treatment market since 2009. These collaborations are a result of the World Health Organization recommendations. They involve strict patient monitoring, providing financial support to patients diagnosed with multidrug-resistant tuberculosis, and close contact investigations. Treatments from public-private collaborations have been beneficial for several tuberculosis patients in Korea as they have generated positive treatment outcomes.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-16477

Key Takeaways from the Korea Tuberculous Meningitis Treatment Market

  • Korea is estimated to become one of Asia Pacific’s lucrative markets for tuberculous meningitis treatments between 2023 and 2033.
  • Factors driving Korea market include the country’s sizable elderly population, rising diabetic population, and increasing number of immigrants from high-burden tuberculosis countries.
  • From 2023 to 2033, the Asia Pacific tuberculous meningitis treatment market is expected to expand at a positive 5% CAGR.
  • In 2023, the global tuberculous meningitis treatment market value is poised to reach US$ 150 billion.
  • A robust 2% CAGR is likely to take the global tuberculous meningitis treatment market’s value to US$ 300 billion in 2033.

“In recent years, Gyeonggi, Seoul, Gyeongbuk, and Busan have reported most of the tuberculosis cases in Korea. Between 2023 and 2033, leading players in Korea tuberculous meningitis treatment market are likely to focus on these cities to launch new drugs,” says a lead analyst at Future Market Insights.

Competition Landscape in the Korea Tuberculous Meningitis Treatment Market

Manufacturers are aiming to evolve their product development processes to meet tuberculosis meningitis treatment requirements across Korea. Few companies are also focusing on new product launches, mergers, and acquisitions.

Pfizer Inc., GSK plc, and Sanofi S.A. are prominent players in the Korea tuberculous meningitis treatment market.

Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-16477

Recent Developments

  • In August 2022, Organon & Co. and Samsung Bioepis Co. announced that their formulation of HADLIMA had been approved by the United States Food and Drug Administration (FDA).

Key Segments Profiled in the Tuberculous Meningitis Treatment Market Survey

By Treatment:

  • Antibiotic Therapy
  • Adjunctive Corticosteroid Therapy
  • Neurosurgical Management

By End User:

  • Hospitals
  • Specialty Clinics
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Liquid Silicone Rubber Market to Record a CAGR of 3.9%, Valuation to Reach US$ 10.1 Billion by the end of 2033

The liquid silicone rubber market is expected to hold a valuation of US$ 6.9 billion in 2023. The market is expected to witness a  3.9% from 2023 to 2033. By 2033, the value is expected to cross US$ 10.1 billion.

The liquid silicone rubbers are equipped with the ability to perform under a wide range of temperatures, ranging from -50 0C to 165 0C. Owing to this, these are majorly used in the aviation industry. Furthermore, these also display excellent resistance to chemicals. Thus, they find application in procedures in the medical sector, including  ENT, heart surgery, etc.

Liquid silicone rubber is witnessing massive demand in the automobile and automotive sectors as well. The ability to provide a superior compression set and to act as a gloss enhancer is expected to surge their application. The silicone rubbers also work as a dampening medium for the instruments in vehicles. The significant surge in demand for electric vehicles represents massive scope for the market. These are being used in power transmission equipment owing to their heat stability.

Surging electronics sector presents lucrative opportunities for the market. Silicone is believed to be the heart of the electronics industry as it assists in encapsulating a bulky circuit into a miniaturized system. The liquid silicone rubbers protect the electronic circuits from shock, heat, and various forms of contaminants. These are also employed in critical electronic components like transistors, capacitors, and tubes in electronic devices.

For insights on global, regional, and country-level parameters with growth opportunities from 2023 to 2033 – Download a sample report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5736

The injection moulding market also makes use of liquid silicone rubbers. This can be attributed to the fact that these silicone rubbers offer high shelf life and provide electrical resistance as well.

Thus, the FMI researchers are of the opinion that the ability to work under extreme conditions, coupled with electrical resistance offered, growth of the electronics sector and a number of other factors, are expected to surge the liquid silicone rubber market growth during the forecast period.

Key Takeaways:

  • The market is projected to be valued at US$ 6.9 billion in 2023.
  • By 2033, the valuation is expected to cross US$ 10.1 billion.
  • The CAGR during the forecast period is predicted to be 3.9%.
  • Based on the regional analysis, North America is anticipated to be the dominant market.
  • The United States market is projected to grow at 3.6%.
  • The United Kingdom market is estimated to surge at 3.4%.
  • China market is forecasted to advance at 3.6%.
  • Japan liquid silicone rubber market is expected to surge at 4.5%.
  • India market is projected to record 4.3%.
  • On the basis of grade type, the industrial grade segment is expected to hold the prominent market share and is expected to register a CAGR of 4%.
  • On the basis of technology, the liquid injection molding system segment is anticipated to hold a significant market share and is projected to record a CAGR of 3.5%.

Competitive Landscape:

The key players operating in the liquid silicone rubber market are expected to form strategic partnerships with players from other niches, especially those from the electronics and automobile sector. There is also a lot of emphasis being laid on the process of mergers and acquisitions. The players who are entering into new markets are focusing on inorganic growth, as the local players would be well-versed with demographic tastes. Furthermore, huge amounts are being invested in technological upgradation with a view to reducing waste accumulation.

In November 2022, Dow selected AB Specialty Silicones as the authorized distributor for elastomeric roof coating market in the United States and Canada.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-5736

Liquid Silicone Rubber Market Segmentation

By Grade Type:

  • Food Grade
  • Industrial Grade
  • Medical Grade
  • Others

By Technology:

  • Liquid Injection Molding System
  • Other Molding Processes

By End-use Industry:

  • Consumer Goods
  • Electrical and Electronics
  • Construction
  • Automotive
  • Healthcare
  • Other Applications

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific Excluding Japan
  • Japan
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com

Global Wind Turbine Composite Materials Market: Contributing to a Sustainable Energy Future

The global wind turbine composite materials market is expected to reach a valuation of US$ 25.4 Billion by 2032, with sales growing at a healthy CAGR of 7.14% from 2022 to 2032. Scaling up from a value of US$ 12 Billion in 2021, the target market is set to reach an estimated US$ 12.75 Billion in 2022.

The increasing wind energy installations along with the rising application of carbon fiber is projected to serve as a major growth driver for the wind turbine composite materials market during the forecast period. Composites are of tremendous importance in the manufacturing of wind turbine rotor blades, one of the key components of the general wind turbine structure.

Owing to the persistent increment in the length of rotor blades so as to raise the wind turbine output, the market for wind turbine composite materials is offered numerous growth opportunities during the projected period. Again, the soaring demand for wind energy leads to the construction of larger wind blades that are more effective and deliver higher output.

Get a Sample Copy of the Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-994

This is anticipated to spearhead the demand for composite materials for blades. Additionally, the advantages of using composites over traditional materials like steel and aluminum are predicted to foster the expansion of the wind turbine composite materials market size during the assessment period.

Composite materials offer several advantages including lower maintenance, corrosion resistance, extended lifecycle, and high strength-to-weight ratio. These benefits will likely underpin the market demand over the forecast period.

The rising demand for composites that further help in improving the strength and providing greater stiffness to structural parts of wind turbines, like nacelles and blades, is expected to drive the demand for such composite materials. This will positively influence the wind turbine composite materials market during the projection period.

“Heightened demand for lightweight materials with greater efficiency is expected to spur the global demand of the wind turbine composite materials market over the forecast period,” says an FMI analyst.  

Key Takeaways:

  • High costs associated with the target product may restrain the growth of the market.
  • Increasing demand for sustainable and clean energy will strengthen the market prospects.
  • The wind turbine composite materials market in North America will grow at a substantial CAGR during the forecast period.
  • Asia Pacific will emerge as one of the most lucrative markets for wind turbine composite materials.
  • By fiber type, the glass fiber segment will contribute significantly to the overall market growth.

Competitive Landscape 

Gurit Holding AG, TPI Composites, Cytec Industries, Teijin Limited, and Rotal Tencate NV among others are some of the major players in the wind turbine composite materials market profiled in the full version of the report. Key market participants are keen on entering markets in emerging economies to develop their manufacturing facilities. These businesses are focusing on product innovation and development to gain a competitive edge.

For any Queries Linked to the Report, Ask an Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-994

More Insights into Wind Turbine Composite Materials Market Report

In its latest report, FMI offers an unbiased analysis of the global wind turbine composite materials market, providing historical data from 2015 to 2020 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of fiber type (carbon fiber, glass fiber), resin (epoxy, vinyl ester, polyester, polyurethane), application (towers, rotor blade, nacelle, hub), and region.

According to the latest FMI reports, based on segmentation, the glass fiber segment is predicted to contribute substantially to the overall market growth. The chemical resistance, good stiffness, and affordability of glass fibers make them a popular choice among end-users.

Key Segments Profiled in the Global Wind Turbine Composite Materials Market

Type of Fiber:

  • Carbon Fiber
  • Glass Fiber

Type of Resin:

  • Epoxy
  • Vinyl Ester
  • Polyester
  • Polyurethane

Click on the Below Link to Buy this Report @
https://www.futuremarketinsights.com/checkout/994

Regional Analysis of Wind Turbine Composite Materials Market

Based on region, the wind turbine composite materials market in North America will present considerable growth. The target market in this region is anticipated to grow at a steady rate during 2022-2032.

Escalating power consumption, implementation of stringent environmental regulations by the U.S. and Canadian governments, and the strong presence of key market participants will drive the growth of the wind turbine composite materials market in North America during the projection period. Apart from, North America, the Asia Pacific region will also present notable growth in the wind turbine composite materials market during 2022-2032.

About Us

Future Market Insights (ESOMAR-certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Browse the latest Market Reports: https://www.futuremarketinsights.com/category/chemicals-and-materials
LinkedIn| Twitter| Blogs